BioLargo, Inc.
BLGO
$0.2365
$0.00351.50%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.01M | -537.00K | -441.00K | -410.00K | -729.00K |
| Total Depreciation and Amortization | 67.00K | 68.00K | 60.00K | 60.00K | 88.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 0.00 |
| Total Other Non-Cash Items | 217.00K | -200.00K | 203.00K | 259.00K | 926.00K |
| Change in Net Operating Assets | -1.19M | -951.00K | 27.00K | 572.00K | -287.00K |
| Cash from Operations | -1.92M | -1.62M | -151.00K | 481.00K | -2.00K |
| Capital Expenditure | 25.00K | -39.00K | -358.00K | -863.00K | -146.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -82.00K | -- | -- | -- | -- |
| Cash from Investing | -57.00K | -39.00K | -358.00K | -863.00K | -146.00K |
| Total Debt Issued | 864.00K | -- | -- | -- | 65.00K |
| Total Debt Repaid | -2.00K | -4.00K | -3.00K | -5.00K | 55.00K |
| Issuance of Common Stock | -- | 768.00K | 1.00M | 1.09M | 606.00K |
| Repurchase of Common Stock | -1.28M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.01M | -- | -- | -- | 35.00K |
| Cash from Financing | 1.59M | 764.00K | 999.00K | 1.08M | 761.00K |
| Foreign Exchange rate Adjustments | 47.00K | 12.00K | -61.00K | 96.00K | -116.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -334.00K | -883.00K | 429.00K | 797.00K | 497.00K |